miR-223下调NLRP3炎性体表达抑制人血管平滑肌细胞分泌高迁移率族蛋白B1

吴伟滨; 汪睿; 武日东; 陈赛; 林敏仪; 王深明; 姚陈

doi:10.16016/j.1000-5404.201801052

您当前的位置：

首页 >

文章列表页 >

miR-223下调NLRP3炎性体表达抑制人血管平滑肌细胞分泌高迁移率族蛋白B1

临床医学 | 更新时间：2026-01-09

- miR-223下调NLRP3炎性体表达抑制人血管平滑肌细胞分泌高迁移率族蛋白B1
- MiR-223 inhibits HMGB1 secretion from human arterial smooth muscle cells by down-regulating NLRP3
- 第三军医大学学报 2018年40卷第15期页码：1399-1406
- 作者机构：
  
  1.510080 广州, 中山大学附属第一医院:血管外科
  2.510080 广州, 中山大学附属第一医院:特需医疗与健康管理中心门诊
  3.516081 广东惠州, 中大惠亚医院外科
- 作者简介：
  
  [ 姚陈, E-mail:yaochen_sums@163.com YAO Chen, E-mail:yaochen_sums@163.com
- 基金信息：
- DOI：10.16016/j.1000-5404.201801052
  中图分类号： R322.121;R392-33;R392.3
- 收稿：2018-01-07，
  
  修回：2018-03-15，
  
  纸质出版：2018-08-15
- 稿件说明：
移动端阅览
吴伟滨, 汪睿, 武日东, 等. miR-223下调NLRP3炎性体表达抑制人血管平滑肌细胞分泌高迁移率族蛋白B1[J]. 第三军医大学学报, 2018,40(15):1399-1406.

Weibin WU, Rui WANG, Ridong WU, et al. MiR-223 inhibits HMGB1 secretion from human arterial smooth muscle cells by down-regulating NLRP3[J]. Journal of Third Military Medical University, 2018, 40(15): 1399-1406.
吴伟滨, 汪睿, 武日东, 等. miR-223下调NLRP3炎性体表达抑制人血管平滑肌细胞分泌高迁移率族蛋白B1[J]. 第三军医大学学报, 2018,40(15):1399-1406. DOI： 10.16016/j.1000-5404.201801052.

Weibin WU, Rui WANG, Ridong WU, et al. MiR-223 inhibits HMGB1 secretion from human arterial smooth muscle cells by down-regulating NLRP3[J]. Journal of Third Military Medical University, 2018, 40(15): 1399-1406. DOI： 10.16016/j.1000-5404.201801052.

摘要

目的

探讨microRNA-223（miR-223）下调人动脉平滑肌细胞（human arterial smooth muscle cells，HASMCs）高迁移率族蛋白B1（high mobility group box 1，HMGB1）分泌的作用机制。

方法

利用我院严重外伤截肢患者或健康器官捐献者的正常动脉组织，通过组织块贴壁法分离原代HASMCs并通过免疫荧光进行鉴定；利用实时荧光定量PCR（real-time quantitative PCR，RT-qPCR）及Western blot检测脂多糖（lipopolysaccharides，LPS）联合腺嘌呤核苷三磷酸（adenosine triphosphate，ATP）对HASMCs中NLRP3（NLR family pyrin domain containing 3）炎性体的激活作用；转染miR-223模拟物（miR-223 mimic）进入HASMCs，利用RT-qPCR、Western blot检测靶基因NLRP3 mRNA、蛋白表达量及激活状态，利用双荧光素酶报告基因明确miR-223和NLRP3的调控关系，通过酶联免疫吸附测定法（ELISA）检测miR-223对HASMCs上清中HMGB1的含量影响。

结果

LPS联合ATP可以激活HASMCs细胞内NLRP3炎性体（

0.05），促进HMGB1胞外分泌（

0.01）；转染miR-223可以显著减少NLRP3 mRNA及蛋白水平（

0.05），通过双荧光素酶报告基因明确NLRP3为miR-223的直接靶基因；转染miR-223可以明显下调HASMCs上清的HMGB1水平（

0.01）。

结论

miR-223可以通过转录后水平下调HASMCs内NLRP3炎性体的表达及激活，从而抑制HASMCs分泌HMGB1。

Abstract

Objective

To investigate the role and mechanism of microRNA-223 (miR-223) in down-regulation of high mobility group box 1 (HMGB1) secretion from human arterial smooth muscle cells (HASMCs).

Methods

HASMCs were isolated from the normal arteries of severe traumatic amputees or healthy donors without arteriosclerosis obliterans by tissue explants adherent and then identified by immunofluorescence assay of SM-α actin. Real-time quantitative PCR (RT-qPCR) and Western blotting were used to detect the activity of NLR family pyrin domain containing 3 (NLRP3) inflammasome in the HASMCs after treatment of lipopolysaccharides (LPS) and adenosine triphosphate (ATP). After transfection of miR-223 mimic

the expression of NLRP3 was detected through RT-qPCR and Western blotting. Dual-luciferase report system was performed to verify the regulatory relationships between miR-223 and NLRP3 after the 3'UTR mutation site of NLRP3 was designed. The level of HMGB1 in the supernatant of transfected HASMCs was measured by enzyme linked immunosorbent assay (ELISA).

Results

Treatment of LPS and ATP enhanced the activity of NLRP3 inflammasome (

0.05)

and improved the secretion of HMGB1 from the HASMCs (

0.05). Transfection of miR-223 mimic significantly down-regulated NLRP3 at both mRNA and protein levels (

0.05). Dual-luciferase report system indicated that NLRP3 was the direct target of miR-223 because of its mRNA 3'-UTR sequences being complementary to miR-223. HMGB1 secretion from HASMCs was remarkably decreased after transfection with miR-223 mimic (

0.01).

Conclusion

miR-223 can decreases expression of NLRP3 inflammasome at transcriptional level and then inhibit its activity

and subsequently suppress the secretion of HMGB1 from HASMCs.

关键词

Keywords

references

LIAPIS C D, AVGERINOS E D, KADOGLOU N P, et al . What a vascular surgeon should know and do about atherosclerotic risk factors[J ] . J Vasc Surg, 2009, 49(5):1348-1354. DOI:10.1016/j.jvs.2008.12.046.

HOSEINI Z, SEPAHVAND F, RASHIDI B, et al . NLRP3 inflammasome:Its regulation and involvement in atherosclerosis[J ] . J Cell Physi, 2018, 233(3):2116-2132. DOI:10.1002/jcp.25930.

WEN H, MIAO E A, TING J P. Mechanisms of NOD-like receptor-associated inflammasome activation[J]. Immunity, 2013, 39(3):432-441. DOI:10.1016/j.immuni.2013.08.037.

WILLINGHAM S B, ALLEN I C, BERGSTRALH D T, et al . NLRP3(NALP3, Cryopyrin) facilitates in vivo caspase-1 activation,necrosis, and HMGB1 release via inflammasome-dependent and-independent pathways[J ] . J Immunol, 2009, 183(3):2008-2015. DOI:10.4049/jimmunol.0900138.

BUI F Q, JOHNSON L, ROBERTS J, et al . Fusobacterium nucleatum infection of gingival epithelial cells leads to NLRP3 inflammasome-dependent secretion of IL-1beta and the danger signals ASC and HMGB1[J ] . Cell Microbiol, 2016, 18(7):970-981. DOI:10.1111/cmi.12560.

KANG R, CHEN R, ZHANG Q, et al . HMGB1 in health and disease[J ] . Mol Aspects Med, 2014, 40:1-116. DOI:10.1016/j.mam.2014.05.001.

VANDE W L, KANNEGANTI T D, LAMKANFI M. HMGB1 release by inflammasomes[J]. Virulence, 2011, 2(2):162-165.

BIANCHI M E, CRIPPA M P, MANFREDI A A, et al . High-mobility group box 1 protein orchestrates res ponses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair[J ] . Immunol Rev, 2017, 280(1):74-82. DOI:10.1111/imr.12601..

UGRINOVA I, PASHEVA E. HMGB1 protein:a therapeutic target inside and outside the cell[J]. Adv Protein Chem Struct Biol, 2017, 107:37-76. DOI:10.1016/bs.apcsb.2016.10.001.

CAI J, WEN J, BAUER E, et al . The role of HMGB1 in cardiovascular biology:danger signals[J ] . Antioxid Redox Signal, 2015, 23(17):1351-1369. DOI:10.1089/ars.2015.6408.

WANG K, LI W, YU Q, et al . High mobility group Box 1 mediates interferon-gamma-induced phenotypic modulation of vascular smooth muscle cells[J ] . J Cell Biochem, 2017, 118(3):518-529. DOI:10.1002/jcb.25682.

HUANG S C, WANG M, WU W B, et al . Mir-22-3p inhibits arterial smooth muscle cell proliferation and migration and neointimal hyperplasia by targeting HMGB1 in arteriosclerosis obliterans[J ] . Cell Physiol Biochem, 2017, 42(6):2492-2506. DOI:10.1159/000480212.

SCHWARTZ S M. Perspectives series:cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis[J]. J Clin Invest, 1997, 99(12):2814-2816. DOI:10.1172/JCI119472.

OWENS G K, KUMAR M S, WAMHOFF B R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease[J]. Physiol Rev, 2004, 84(3):767-801. DOI:10.1152/physrev.00041.2003.

FARH K K, GRIMSON A, JAN C, et al . The widespread impact of mammalian MicroRNAs on mRNA repression and evolution[J ] . Science, 2005, 310(5755):1817-1821. DOI:10.1126/science.1121158.

SHAN Z, QIN S, LI W, et al . An endocrine genetic signal between blood cells and vascular smooth muscle cells:role of microRNA-223 in smooth muscle function and atherogenesis[J ] . J Am Coll Cardiol, 2015, 65(23):2526-2537. DOI:10.1016/j.jacc.2015.03.570.

LU X, KAKKAR V. Inflammasome and atherogenesis[J]. Curr Pharm Des, 2014, 20(1):108-124.

周超, 季新忠, 刘巧, 等.炎症诱导SCAP功能失调促进ApoE-/-小鼠动脉粥样硬化的分子机制[J].第三军医大学学报, 2016, 38(9):938-943. DOI:10.16016/j.1000-5404.201510111.

ZHOU C, JI X Z, LIU Q, et al .Molecular mechanism of cholesterol sensor SCAP dysfunction in athero ma formation in ApoE-/-mice induced by inflammation[J ] .J Third Mil Med Univ, 2016, 38(9):938-943. DOI:10.16016/j.1000-5404.201510111.

GROH L, KEATING S T, JOOSTEN L, et al . Monocyte and macrophage immunometabolism in atherosclerosis[J ] . Semin Immunopathol, 2018, 40(2):203-214. DOI:10.1007/s00281-017-0656-7.

TALL A R, YVAN-CHARVET L. Cholesterol, inflammation and innate immunity[J]. Nat Rev Immunol, 2015, 15(2):104-116. DOI:10.1038/nri3793.

HANEKLAUS M, O'NDILL L A, COLL R C. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation:recent developments[J]. Curr Opin Immunol, 2013, 25(1):40-45. DOI:10.1016/j.coi.2012.12.004.

GREBE A, LATZ E. Cholesterol crystals and inflammation[J]. Curr Rheumatol Rep, 2013, 15(3):313. DOI:10.1007/s11926-012-0313-z.

SAMSTAD E O, NIYONZIMA N, NYMO S, et al . Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release[J ] . J Immunol, 2014, 192(6):2837-2845. DOI:10.4049/jimmunol.1302484.

JIANG Y, WANG M, HUANG K, et al . Oxidized low-density lipoprotein induces secretion of interleukin-1beta by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation[J ] . Biochem Biophys Res Commun, 2012, 425(2):121-126. DOI:10.1016/j.bbrc.2012.07.011..

HOSEINI Z, SEPAHVAND F, RASHIDI B, et al . NLRP3 inflammasome:Its regulation and involvement in atherosclerosis[J ] . J Cell Physiol, 2018, 233(3):2116-2132. DOI:10.1002/jcp.25930.

BENNETT M R, SINHA S, OWENS G K. Vascular smooth muscle cells in atherosclerosis[J]. Circ Res, 2016, 118(4):692-702. DOI:10.1161/CIRCRESAHA.115.306361.

LACOLLEY P, REGNAULT V, SEGERS P, et al . Vascular smooth muscle cells and arterial stiffening:relevance in development, aging, and disease[J ] . Physiol Rev, 2017, 97(4):1555-1617. DOI:10.1152/physrev.00003.2017.

YIN Y W, LIAO S Q, ZHANG M J, et al . TLR4-mediated inflammation promotes foam cell formation of vascular smooth muscle cell by upregulating ACAT1 expression[J ] . Cell Death Dis, 2014, 5:e1574. DOI:10.1038/cddis.2014.535.

FISHER E A, MIANO J M. Don't judge books by their covers:vascular smooth muscle cells in arterial pathologies[J]. Circulation, 2014, 129(15):1545-1547. DOI:10.1161/CIRCULATIONAHA.114.009075.

VENGRENYUK Y, NISHI H, LONG X, et al . Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype[J ] . Arterioscler Thromb Vasc Biol, 2015, 35(3):535-546. DOI:10.1161/ATVBAHA.114.304029.

SCAFFIDI P, MISTELI T, BIANCHI M E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation[J]. Nature, 2002, 418(6894):191-195. DOI:10.1038/nature00858.

PORTO A, PALUMBO R, PIERONI M, et al . Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein[J ] . FASEB J, 2006, 20(14):2565-2566. DOI:10.1096/fj.06-5867fje.

BAUERNFEIND F, RIEGER A, SCHILDBERG F A, et al . NLRP3 inflammasome activity is negatively controlled by miR-223[J ] . J Immunol, 2012, 189(8):4175-4181. DOI:10.4049/jimmunol.1201516.

NEUDECKER V, HANEKLAUS M, JENSEN O, et al . Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome[J ] . J Exp Med, 2017, 214(6):1737-1752. DOI:10.1084/jem.20160462..

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

炎症诱导SCAP功能失调促进ApoE^-/-小鼠动脉粥样硬化的分子机制

野马追提取液对动脉粥样硬化家兔炎症反应的防治作用

MAVS功能丧失性突变导致抗病毒免疫缺陷：揭示病毒感染触发儿童泛发性脓疱性银屑病的新机制

Z-藁本内酯通过抑制PI3K/AKT信号通路延缓视网膜色素变性：基于网络药理学与分子对接验证

ATF3通过抑制ATG5和ATG16L1表达调控巨噬细胞自噬与炎症反应